Tango Therapeutics, Inc. (TNGX)
NGM · Common · CUSIP 05492W103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TNGX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
05492W103
Market Cap
Small Cap
IPO
9/3/2020 · $10.00/share
Previous Symbol
BCTG (changed 9/29/2021)
Previous Name
BCTG Acquisition Corp.
Business: Tango Therapeutics, Inc. is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.

Company Contact

CEO
Barbara Weber
CFO
Daniella Beckman
Headquarters
201 Brookline Ave., Suite 901, Boston, MA
Phone
857-320-4900
Investor Relations
Elizabeth Hickin · 212-600-1902 · ehickin@tangotx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »